A detailed history of Sbi Securities Co., Ltd. transactions in Nkarta, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 104 shares of NKTX stock, worth $248. This represents 0.0% of its overall portfolio holdings.

Number of Shares
104
Holding current value
$248
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$2.17 - $4.34 $225 - $451
104 New
104 $259,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $116M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.